Clozapine prescribing in COVID-19 positive medical inpatients: a case series
There is both uncertainty regarding the safety of clozapine in COVID-19 patients owing to limited published data and a lack of consensus on continuing clozapine in patients with severe respiratory infections. COVID-19 is known to induce an acute immune response which can affect haematological parame...
Saved in:
Main Authors: | Matthew Butler (Author), Felicity Bano (Author), Marilia Calcia (Author), Isabel McMullen (Author), Chun Chiang Sin Fai Lam (Author), Laura Jane Smith (Author), David Taylor (Author), Siobhan Gee (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reasons for admission to a general medical hospital for patients taking clozapine
by: Siobhan Gee, et al.
Published: (2022) -
The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine
by: Siobhan Gee, et al.
Published: (2020) -
Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024) -
Management of clozapine treatment during the COVID-19 pandemic
by: Siobhan Gee, et al.
Published: (2020) -
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
by: Ebenezer Oloyede, et al.
Published: (2022)